Why has Truepill's prescription fulfillment service seen a 15% drop in on-time deliveries over the past month?

Introduction

Truepill's 15% drop in on-time prescription fulfillment deliveries over the past month is a critical issue that demands immediate attention. This decline directly impacts customer satisfaction, medication adherence, and the company's reputation in the competitive healthcare technology landscape. I'll approach this problem systematically, focusing on identifying the root cause, validating hypotheses, and developing both short-term fixes and long-term strategic solutions.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a recent change in operations. Has Truepill implemented any new fulfillment processes or technologies in the past 1-2 months?

Why it matters: Recent changes often correlate with performance shifts. Expected answer: Yes, a new inventory management system was implemented. Impact on approach: If true, I'd focus on system integration and staff training issues.

• Considering the scale of the drop, I'm wondering about supply chain disruptions. Have there been any significant changes or issues with Truepill's pharmaceutical suppliers recently?

Why it matters: Supply chain problems can directly impact fulfillment times. Expected answer: No major supplier changes, but some delays in receiving certain medications. Impact on approach: I'd investigate inventory management and forecasting processes.

• Given the specificity of the 15% drop, I'm curious about the measurement methodology. Has there been any change in how on-time deliveries are tracked or defined?

Why it matters: Metric definition changes can sometimes explain apparent performance shifts. Expected answer: No changes in measurement methodology. Impact on approach: If confirmed, I'd focus on operational rather than reporting issues.

• Thinking about customer segments, I'm wondering if this is a universal issue. Is the 15% drop consistent across all customer types and medication categories?

Why it matters: Segmented analysis can reveal targeted problems vs. systemic issues. Expected answer: The drop is more pronounced for certain medication types or customer segments. Impact on approach: I'd prioritize investigating the most affected segments for quick wins.